Vuslat Akçay

Ms. Vuslat Akçay

DKFZ, Heidelberg, Baden-Württemberg, Germany
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
NDNareg Degirmenci
Nareg Degirmenci
İEİlknur Sur Erdem
İlknur Sur Erdem
VAVuslat Akçay
Vuslat Akçay
YBYasemin Bolukbasi
Yasemin Bolukbasi
USUgur Selek
Ugur Selek
TBTugba Bagci-Onder
Tugba Bagci-Onder
Glioblastoma is the most common type of primary brain tumor with an aggressive clinical course, and one of the cornerstones in its treatment regimen is radiotherapy. However, tumor cells surviving after radiation is an indicator of treatment failure; therefore, better understanding of the molecular mechanisms regulating radiotherapy response is of utmost importance. In this study, we generated multiple clinically relevant irradiation exposed models, where we applied fractionated radiotherapy over a long period of time and selected irradiation-survivor (IR-Surv) glioblastoma cell populations. In these cells, we examined the transcriptomic alterations, cell cycle and growth rate changes as well as responses to secondary radiotherapy and DNA damage response (DDR) modulators. Accordingly, IR-Surv cells exhibited slower growth and partly retained their ability to resist secondary irradiation. Transcriptomic analysis revealed that IR-Surv cells upregulated the expression of DDR-related genes, such as CHK1, ATM, ATR, MGMT, and had better DNA repair capacity as an adaptive mechanism. Separately, we report IR-Surv cells to display downregulation of hypoxic signature and the lower induction of hypoxia target genes and not exhibiting the same level of hypoxia-induced changes with naïve glioblastoma cells, as gauged by exposing cells to different hypoxia conditions. We also showed that Chk1 inhibition alone or in combination with irradiation significantly reduces cell viability in both naïve and IR-Surv cells. However, IR-Surv cells were markedly less sensitive to Chk1 inhibition under hypoxic conditions. In conclusion, consistent with previous reports, we demonstrate the utility of combining DDR inhibitors and irradiation as a successful approach for both naïve and IR-Surv glioblastoma cells as long as cells are refrained from hypoxic conditions. Thus, our findings with clinically relevant radiation survivor models will have future translational implications and benefit the optimization of combination therapies for glioblastoma patients.

6 August 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
LFLeo Carl Foerster
Leo Carl Foerster
OKOguzhan Kaya
Oguzhan Kaya
VWValentin Wüst
Valentin Wüst
DDDiana-Patricia Danciu
Diana-Patricia Danciu
VAVuslat Akçay
Vuslat Akçay
AMAna Martin-Villalba
Ana Martin-Villalba
The growth of a tumor is tightly linked to the distribution of its cells along a continuum of activation states. Here, we systematically decode the activation state architecture (ASA) in a glioblastoma (GBM) patient cohort through comparison to adult murine neural stem cells. Modelling of these data forecasts how tumor cells organize to sustain growth and identifies the rate of activation as the main predictor of growth. Accordingly, patients with a higher quiescence fraction exhibit improved outcomes. Further, DNA methylation arrays enable ASA-related patient stratification. Comparison of healthy and malignant gene expression dynamics reveals dysregulation of the Wnt-antagonist SFRP1 at the quiescence to activation transition. SFRP1 overexpression renders GBM quiescent and increases the overall survival of tumor-bearing mice. Surprisingly, it does so through reprogramming the tumor’s stem-like methylome into an astrocyte-like one. Our findings offer a framework for patient stratification with prognostic value, biomarker identification, and therapeutic avenues to halt GBM progression.

28 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
VAVuslat Akçay
Vuslat Akçay
LSLisa M. Spaenig
Lisa M. Spaenig
WVWouter-Michiel A.M. Vierdag
Wouter-Michiel A.M. Vierdag
PJPiyush Joshi
Piyush Joshi
PSPatricia Benites Goncalves da Silva
Patricia Benites Goncalves da Silva
LKLena M. Kutscher
Lena M. Kutscher
The rhombic lip (RL) gives rise to all cerebellar glutamatergic cell types, including unipolar brush cells (UBCs). Disruptions to UBC development can lead to the neurodevelopmental disorder Dandy-Walker Syndrome and the pediatric brain tumor medulloblastoma, but these diseases have not been adequately modeled in mice. To evaluate conservation of UBC development in mouse and human, we examined UBC localization, lineage decisions, and the underlying molecular mechanisms of UBC differentiation using multiplex immunofluorescence and single-cell RNA-seq of wild-type and conditional knockout animals of the primary UBC transcription factor Eomes. Similar to the human RL, the murine RL is molecularly compartmentalized, cycling EOMES+ UBC progenitors are highly abundant, and persist after birth. Eomes regulates the transcriptional networks important for UBC differentiation and migration, but not UBC fate. Overall, our findings suggest that murine UBC development recapitulates many features of human UBC development, with EOMES playing a central role in UBC maturation.

17 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
LFLeo Carl Foerster
Leo Carl Foerster
OKOguzhan Kaya
Oguzhan Kaya
VWValentin Wüst
Valentin Wüst
DDDiana-Patricia Danciu
Diana-Patricia Danciu
VAVuslat Akçay
Vuslat Akçay
AMAna Martin-Villalba
Ana Martin-Villalba

25 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LBLuca Bianchini
Luca Bianchini
RXRuijie Xu
Ruijie Xu
DFDavid Filipovic
David Filipovic
PSPatricia Benites Goncalves da Silva
Patricia Benites Goncalves da Silva
LSLaura Sieber
Laura Sieber
LKLena M. Kutscher
Lena M. Kutscher
Boys experience an overall increased incidence of several childhood cancers, including medulloblastoma, a clinically heterogeneous cerebellar tumor. In subtypes of Group 3 and Group 4 medulloblastoma, males are three times more prevalent than females. As medulloblastoma is suspected to initiate during fetal development, we hypothesized that this sex bias reflects a combination of prenatal, sex-specific developmental processes and somatic alterations. To test these hypotheses, we compiled a large multi-omics dataset from children with medulloblastoma, which revealed sex-specific alterations, including frequent loss of the inactive X chromosome in females with Group 4. Generation of a sex-matched single-cell transcriptome atlas of the developing murine cerebellum enabled investigation of putative developmental factors underlying sex bias. Progenitors giving rise to Group 3/4 subgroups were more abundant, more proliferative, and harbored more open chromatin for recruitment of LMX1A and OTX2, master transcription factors defining Group 3/4 identity. Advanced genetically engineered mouse models and human cerebellar organoids were leveraged to determine whether sexual dimorphism arises from intrinsic or extrinsic factors. These models showed that the XY genotype contributed to the phenotype, but the predominant effect was driven by presence of the male gonadal hormone testosterone. Our findings provide a sex-specific genetic and neurodevelopmental explanation for male bias in an aggressive pediatric brain tumor. Outcomes from this study may inform novel treatment strategies delivered according to sex and are likely to be broadly applicable to other sex-biased malignancies arising in early life.